The incidence of new tuberculosis cases in the United States in 2014 decreased 2.2% from 2013, but is the smallest decline in more than a decade, according to new data.

Adding Lamprene to current tuberculosis therapy demonstrated higher treatment success than standard treatment alone in treating multidrug-resistant tuberculosis, researchers in China have found.